safety

FDA approves Indivior’s long-lasting opioid withdrawal therapy

https://pharmaphorum.com/news/fda-long-lasting-opioid-sublocade/

Viagra to become available in UK pharmacies

https://pharmaphorum.com/news/viagra-become-available-uk-pharmacies/

FDA encourages cheap abuse-deterrent painkillers

https://pharmaphorum.com/news/fda-publishes-guidance-encouraging-abuse-deterrent-painkillers/

Acorda shares crash after deaths in Parkinson’s trials

https://pharmaphorum.com/news/acorda-shares-crash-deaths-parkinsons-trials/

Cellectis gets FDA go-ahead to restart fatal CAR-T trial

https://pharmaphorum.com/news/cellectis-gets-fda-go-ahead-restart-fatal-car-t-trial/

FDA cracks down on bogus cannabis cancer cures

https://pharmaphorum.com/news/fda-cracks-bogus-cannabis-cancer-cures/

Bayer left playing catch-up with BMS after Xarelto failure

https://pharmaphorum.com/news/bayer-bms-xarelto-failure/

J&J hopes FDA cardio label will limit Invokana damage

https://pharmaphorum.com/news/jj-hopes-fda-cardio-benefit-label-will-limit-damage-invokana/

Novo’s Tresiba primed for key ‘hypo’ label update in EU

https://pharmaphorum.com/news/novos-tresiba-gets-key-hypo-label-update-eu/

«< 3 4 5 6 7 >»

Close in 10 seconds

Pharmaphorum.com

Search